Analysis | Samples | Factors | Units |
---|---|---|---|
Reversed phase NEGATIVE ION MODE | F01_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F01_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F01_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F04_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F04_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F04_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F05_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F05_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F05_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F08_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F08_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F08_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F09_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F09_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F09_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F11_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F11_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F11_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F15_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F15_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F15_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F16_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F16_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F16_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F17_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F17_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F17_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F20_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F20_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F20_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F24_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F24_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F24_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F26_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F26_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F26_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F29_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F29_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F29_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F31_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F31_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F31_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F32_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F32_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F32_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L06_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L06_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L06_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L07_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L07_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L07_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L08_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L08_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L08_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L10_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L10_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L10_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L12_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L12_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L12_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L14_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L14_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L14_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L16_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L16_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L16_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L18_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L18_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L18_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L22_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L22_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L22_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L28_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L28_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L28_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L30_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L30_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L30_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L33_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L33_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L33_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L35_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L35_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L35_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L40_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L40_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L40_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P02_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P02_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P02_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P03_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P03_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P03_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P07_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P07_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P07_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P11_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P11_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P11_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P15_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P15_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P15_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P18_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P18_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P18_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P22_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P22_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P22_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P23_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P23_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P23_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P26_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P26_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P26_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P30_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P30_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P30_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P31_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P31_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P31_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P34_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P34_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P34_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P39_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P39_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P39_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P40_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P40_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P40_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P43_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P43_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P43_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P44_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P44_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P44_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P46_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P46_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P46_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P47_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P47_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P47_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P48_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P48_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P48_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P52_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P52_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P52_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P55_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P55_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P55_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P60_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P60_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P60_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P62_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P62_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P62_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P64_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P64_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P64_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F02_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F02_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F02_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F03_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F03_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F03_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F06_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F06_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F06_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F07_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F07_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F07_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F10_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F10_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F10_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F12_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F12_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F12_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F13_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F13_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F13_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F14_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F14_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F14_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F18_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F18_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F18_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F21_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F21_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F21_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F23_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F23_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F23_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F25_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F25_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | F25_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L01_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L01_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L01_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L03_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L03_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L03_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L09_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L09_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L09_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L11_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L11_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L11_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L13_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L13_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L13_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L15_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L15_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L15_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L17_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L17_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L17_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L21_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L21_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L21_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L23_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L23_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L23_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L24_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L24_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L24_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L29_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L29_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L29_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L31_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L31_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L31_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L37_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L37_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L37_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L38_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L38_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | L38_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P01_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P01_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P01_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P05_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P05_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P05_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P06_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P06_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P06_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P09_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P09_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P09_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P12_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P12_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P12_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P13_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P13_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P13_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P16_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P16_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P16_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P17_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P17_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P17_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P20_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P20_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P20_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P21_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P21_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P21_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P24_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P24_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P24_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P28_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P28_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P28_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P29_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P29_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P29_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P32_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P32_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P32_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P33_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P33_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P33_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P35_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P35_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P35_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P37_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P37_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P37_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P41_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P41_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P41_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P42_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P42_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P42_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P49_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P49_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P49_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P50_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P50_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P50_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P61_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P61_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P61_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P63_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P63_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P63_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P65_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P65_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase NEGATIVE ION MODE | P65_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F01_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F01_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F01_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F04_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F04_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F04_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F05_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F05_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F05_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F08_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F08_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F08_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F09_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F09_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F09_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F11_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F11_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F11_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F15_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F15_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F15_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F16_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F16_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F16_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F17_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F17_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F17_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F20_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F20_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F20_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F24_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F24_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F24_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F26_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F26_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F26_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F29_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F29_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F29_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F31_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F31_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F31_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F32_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F32_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F32_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L06_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L06_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L06_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L07_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L07_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L07_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L08_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L08_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L08_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L10_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L10_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L10_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L12_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L12_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L12_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L14_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L14_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L14_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L16_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L16_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L16_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L18_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L18_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L18_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L22_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L22_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L22_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L28_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L28_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L28_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L30_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L30_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L30_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L33_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L33_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L33_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L35_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L35_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L35_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L40_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L40_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L40_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P02_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P02_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P02_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P03_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P03_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P03_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P07_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P07_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P07_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P11_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P11_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P11_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P15_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P15_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P15_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P18_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P18_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P18_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P22_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P22_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P22_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P23_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P23_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P23_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P26_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P26_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P26_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P30_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P30_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P30_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P31_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P31_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P31_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P34_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P34_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P34_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P39_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P39_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P39_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P40_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P40_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P40_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P43_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P43_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P43_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P44_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P44_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P44_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P46_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P46_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P46_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P47_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P47_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P47_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P48_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P48_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P48_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P52_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P52_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P52_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P55_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P55_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P55_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P60_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P60_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P60_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P62_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P62_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P62_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P64_V1 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P64_V4 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P64_V6 | Treatedrial arm:Treated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F02_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F02_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F02_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F03_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F03_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F03_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F06_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F06_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F06_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F07_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F07_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F07_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F10_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F10_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F10_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F12_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F12_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F12_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F13_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F13_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F13_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F14_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F14_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F14_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F18_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F18_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F18_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F21_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F21_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F21_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F23_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F23_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F23_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F25_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F25_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | F25_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L01_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L01_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L01_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L03_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L03_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L03_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L09_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L09_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L09_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L11_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L11_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L11_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L13_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L13_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L13_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L15_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L15_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L15_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L17_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L17_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L17_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L21_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L21_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L21_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L23_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L23_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L23_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L24_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L24_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L24_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L29_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L29_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L29_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L31_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L31_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L31_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L37_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L37_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L37_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L38_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L38_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | L38_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P01_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P01_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P01_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P05_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P05_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P05_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P06_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P06_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P06_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P09_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P09_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P09_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P12_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P12_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P12_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P13_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P13_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P13_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P16_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P16_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P16_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P17_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P17_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P17_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P20_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P20_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P20_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P21_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P21_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P21_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P24_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P24_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P24_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P28_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P28_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P28_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P29_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P29_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P29_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P32_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P32_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P32_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P33_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P33_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P33_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P35_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P35_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P35_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P37_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P37_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P37_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P41_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P41_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P41_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P42_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P42_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P42_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P49_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P49_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P49_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P50_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P50_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P50_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P61_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P61_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P61_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P63_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P63_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P63_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P65_V1 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P65_V4 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |
Reversed phase POSITIVE ION MODE | P65_V6 | Treatedrial arm:Untreated | peak area (pareto-scaled, log2-transformed, 24h creatinine normalised) |